CLL / SLL Opening Trials & Status Updates
Opening Trials & Status Updates
Clinical Trials can greatly broaden the potential for effective treatment for your CLL. When CLL / SLL trials open, close, have important amendments, holds, or are affected by other regulatory news, we will report on it here.
Action Items for Opening Trials & Status Updates
Watch this page.
This is where we report the latest news concerning clinical trials.
Study up.
Knowing common inclusion and exclusion criteria for a future clinical trial can be helpful when planning CLL / SLL treatments.
Be ready.
Timing can be important. Clinical trials open and close and sometimes one might need to move quickly if the perfect trial is open.
Be aware and don’t jump to conclusions.
Trials may be closed or paused for many reasons completely unrelated to safety or efficacy.
Watch this page.
This is where we report the latest news concerning clinical trials.
Study up.
Knowing common inclusion and exclusion criteria for a future clinical trial can be helpful when planning CLL / SLL treatments.
Be ready.
Timing can be important. Clinical trials open and close and sometimes one might need to move quickly if the perfect trial is open.
Be aware and don’t jump to conclusions.
Trials may be closed or paused for many reasons completely unrelated to safety or efficacy.
FEATURE
BTK Degrader Offers Promise in Relapsed and Refractory CLL
Bottom Line:
In heavily treated chronic lymphocytic leukemia patients who have poor prognoses and few options, the BTK degrader, NX-5948, saw 7 of the 10 treated respond.
Who Performed the Research and Where Was it Presented:
Dr. Kim Linton led an international group of researchers to present the oral abstract of these encouraging first results on the last day of the 2024 European Hematology Association (EHA) Annual Meeting in Madrid.
ADDITIONAL READING
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
